Literature DB >> 18338089

Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): assessment of joint mobility and grip and pinch strength.

Antonio Cardoso-Santos1, Ana C M M Azevedo, Simone Fagondes, Maira G Burin, Roberto Giugliani, Ida V D Schwartz.   

Abstract

OBJECTIVE: To describe the profile of joint mobility and grip and pinch strength of MPS VI patients and to correlate this with urinary excretion of glycosaminoglycans (GAGs), ARSB activity, and the distance covered in a 6-minute walking test (6MWT).
METHODS: This was an observational study of 28 patients with MPS VI, who had not undergone specific treatment. All patients were assessed for amplitude of joint mobility (shoulder, elbow, and knee), grip and pinch strength and urinary GAG excretion and also performed the 6MWT.
RESULTS: Shoulder flexion exhibited the greatest limitation, with no correlation with age, followed by knee extension and elbow flexion, both of which were correlated inversely with age. Hand grip strength was compromised in all patients, and pinch strength exhibited a positive correlation with age.
CONCLUSIONS: The fact that restricted shoulder flexion was not correlated with age suggests that this finding is present early on in MPS VI and that it constitutes an important clinical sign that should arouse diagnostic suspicion of this disease. The amplitude of knee extension and elbow flexion, in turn, are possible markers of disease progression since they have a negative correlation with age. Further studies are needed to confirm these hypotheses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18338089     DOI: 10.2223/JPED.1743

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  10 in total

1.  Isokinetic muscle strength differences in patients with mucopolysaccharidosis I, II, and VI.

Authors:  Natalie E Taylor; Donald R Dengel; Troy C Lund; Kyle D Rudser; Paul J Orchard; Julia Steinberger; Chester B Whitley; Lynda E Polgreen
Journal:  J Pediatr Rehabil Med       Date:  2014

Review 2.  Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI.

Authors:  Marcela Junqueira Brunelli; Álvaro N Atallah; Edina Mk da Silva
Journal:  Cochrane Database Syst Rev       Date:  2021-09-17

Review 3.  Mucopolysaccharidosis VI.

Authors:  Vassili Valayannopoulos; Helen Nicely; Paul Harmatz; Sean Turbeville
Journal:  Orphanet J Rare Dis       Date:  2010-04-12       Impact factor: 4.123

Review 4.  Assessing the impact of the five senses on quality of life in mucopolysaccharidoses.

Authors:  Roberto Giugliani; Paul Harmatz; Shuan-Pei Lin; Maurizio Scarpa
Journal:  Orphanet J Rare Dis       Date:  2020-04-19       Impact factor: 4.123

5.  Fifteen years of enzyme replacement therapy for mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a case report.

Authors:  Isadora Andrade; River Ribeiro; Zumira A Carneiro; Roberto Giugliani; Catarina Pereira; Claudia Cozma; Daniel Grinberg; Lluïsa Vilageliu; Charles M Lourenco
Journal:  J Med Case Rep       Date:  2022-01-25

6.  Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): defining and measuring functional impacts in pediatric patients.

Authors:  Beth Leiro; Dawn Phillips; Melanie Duiker; Paul Harmatz; Sharon Charles
Journal:  Orphanet J Rare Dis       Date:  2021-12-02       Impact factor: 4.123

7.  A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase.

Authors:  Regina P El Dib; Gregory M Pastores
Journal:  Biologics       Date:  2009-10-12

Review 8.  Diagnostic and treatment strategies in mucopolysaccharidosis VI.

Authors:  Filippo Vairo; Andressa Federhen; Guilherme Baldo; Mariluce Riegel; Maira Burin; Sandra Leistner-Segal; Roberto Giugliani
Journal:  Appl Clin Genet       Date:  2015-10-30

9.  Sensory-motor behavioral characterization of an animal model of Maroteaux-Lamy syndrome (or Mucopolysaccharidosis VI).

Authors:  Paola Saccone; Gabriella Cotugno; Fabio Russo; Rosa Mastrogiacomo; Alessandra Tessitore; Alberto Auricchio; Elvira De Leonibus
Journal:  Sci Rep       Date:  2014-01-10       Impact factor: 4.379

10.  Quality of life in mucopolysaccharidoses: construction of a specific measure using the focus group technique.

Authors:  M R Oliveira; I Schwartz; L S Costa; H Maia; M Ribeiro; L B Guerreiro; A Acosta; N S Rocha
Journal:  BMC Res Notes       Date:  2018-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.